Israel’s Redhill Biopharma signs deal for potential COVID-19 treatment

Redhill Biopharma Ltd has signed a manufacturing deal with two companies in Europe and Canada to ramp up production of its coronavirus treatment candidate, the Israeli drugmaker said on Thursday. The …

( read original story …)